Evolution of a rare vaccine-derived multirecombinant poliovirus

Area of Science:

• Virology
• Molecular Biology
• Genetics

Background:

• Viral genome recombination is a key driver of viral evolution.
• Vaccine-derived poliovirus strains can undergo recombination.
• Vaccine-associated paralytic poliomyelitis (VAPP) is a rare complication of oral poliovirus vaccine (OPV) administration.

Purpose of the Study:

• To characterize a rare vaccine-derived poliovirus strain isolated from a VAPP case.
• To determine the genomic structure and recombination pattern of the poliovirus isolate.
• To perform evolutionary analysis of the identified recombination events.

Main Methods:

• Isolation and characterization of the poliovirus strain from a patient.
• Restriction fragment length polymorphism (RFLP) analysis to determine genomic structure.
• Sanger sequencing to confirm the primary genomic structure and identify mutations.

Main Results:

• A vaccine-derived poliovirus strain with an S2/S1/S2/S1 genomic structure was identified.
• The middle S1/S2 region recombination is a rare event, with Sabin type 1 as a 5' partner.
• Evolutionary analysis revealed mutations and proposed a hypothesis for the order of recombination events.

Conclusions:

• This study describes a rare poliovirus recombination event contributing to viral evolution.
• The findings enhance understanding of poliovirus genetic diversity and VAPP pathogenesis.
• Further research into rare recombination events is crucial for poliovirus eradication efforts.